Health News
FONT-SIZE Plus   Neg
Share SHARE

FDA Warns That Some Oral Contraceptives May Increase Blood Clot Risk

FDA Warns That Some Oral Contraceptives May Increase Blood Clot Risk

The FDA released on Tuesday a new warning about oral contraceptive pills using the drug drospirenone. According to the administration, drugs including Beyaz, Gianvi, Loryna, Ocella, Safyral, Syeda, Yasmin, Yaz, and Zarah, could cause roughly three times the risk of blood clots as those without drospirenone.

The FDA launched a safety inquiry into the pills last year and their report says they have "concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills."

Each of the nine pills will now carry a new warning label explaining the increased risk. The FDA adds, however, that it's still unclear if it was the behavior of some patients taking these drugs that increased the risk:

"The studies also did not account for important patient characteristics (known and unknown) that may influence prescribing and that likely affect the risk of blood clots. For these reasons, it is unclear whether the increased risk seen for blood clots in some of the epidemiologic studies is actually due to drospirenone-containing birth control pills," the FDA adds.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Health News

comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.